
### [Orphanet:165985](http://www.orpha.net/ORDO/Orphanet_165985)
**Label:** Diazoxide-sensitive diffuse hyperinsulinism

**Subclasses:** [Orphanet:71212](http://www.orpha.net/ORDO/Orphanet_71212) (Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), [Orphanet:35878](http://www.orpha.net/ORDO/Orphanet_35878) (Hyperinsulinism-hyperammonemia syndrome), [Orphanet:79299](http://www.orpha.net/ORDO/Orphanet_79299) (Hyperinsulinism due to glucokinase deficiency), [Orphanet:276575](http://www.orpha.net/ORDO/Orphanet_276575) (Autosomal dominant hyperinsulinism due to SUR1 deficiency), [Orphanet:165991](http://www.orpha.net/ORDO/Orphanet_165991) (Exercise-induced hyperinsulinism), [Orphanet:276580](http://www.orpha.net/ORDO/Orphanet_276580) (Autosomal dominant hyperinsulinism due to Kir6.2 deficiency), 

**Corr. equiv. classes:** [OMIM:602485](http://purl.obolibrary.org/obo/OMIM_602485), [Orphanet:35878](http://www.orpha.net/ORDO/Orphanet_35878), [OMIM:601820](http://purl.obolibrary.org/obo/OMIM_601820), [OMIM:609975](http://purl.obolibrary.org/obo/OMIM_609975), [OMIM:610021](http://purl.obolibrary.org/obo/OMIM_610021), [OMIM:231530](http://purl.obolibrary.org/obo/OMIM_231530), [Orphanet:276575](http://www.orpha.net/ORDO/Orphanet_276575), [Orphanet:71212](http://www.orpha.net/ORDO/Orphanet_71212), [OMIM:606762](http://purl.obolibrary.org/obo/OMIM_606762), [Orphanet:79299](http://www.orpha.net/ORDO/Orphanet_79299), [OMIM:256450](http://purl.obolibrary.org/obo/OMIM_256450), [Orphanet:165991](http://www.orpha.net/ORDO/Orphanet_165991), [Orphanet:276580](http://www.orpha.net/ORDO/Orphanet_276580), 

**Class expressions from DL-Learner:**

- [HP:0000825](http://purl.obolibrary.org/obo/HP_0000825) (Hyperinsulinemic hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 69.23%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 69.23%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 69.23%
- [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0003117](http://purl.obolibrary.org/obo/HP_0003117) (Abnormality of circulating hormone level) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 69.23%
- [HP:0000842](http://purl.obolibrary.org/obo/HP_0000842) (Hyperinsulinemia) and [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 69.23%
- [HP:0000825](http://purl.obolibrary.org/obo/HP_0000825) (Hyperinsulinemic hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) 69.23%
- [HP:0000825](http://purl.obolibrary.org/obo/HP_0000825) (Hyperinsulinemic hypoglycemia) and [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 69.23%
- [HP:0004372](http://purl.obolibrary.org/obo/HP_0004372) (Reduced consciousness/confusion) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 65.38%
- [HP:0001259](http://purl.obolibrary.org/obo/HP_0001259) (Coma) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) 65.38%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 65.38%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 65.38%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 65.38%
- [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 65.38%
- [HP:0004372](http://purl.obolibrary.org/obo/HP_0004372) (Reduced consciousness/confusion) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040215](http://purl.obolibrary.org/obo/HP_0040215) (Abnormal circulating insulin level) 65.38%
- [HP:0004372](http://purl.obolibrary.org/obo/HP_0004372) (Reduced consciousness/confusion) and [HP:0004510](http://purl.obolibrary.org/obo/HP_0004510) (Pancreatic islet-cell hyperplasia) and [HP:0040214](http://purl.obolibrary.org/obo/HP_0040214) (Abnormal insulin level) 65.38%


